Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]pip eridine

Details for Australian Patent Application No. 2008228637 (hide)

Owner H. Lundbeck A/S

Inventors Lasskogen, Gudrun; Lopez De Diego, Heidi; Stensbol, Tine Bryan

Agent Watermark

Pub. Number AU-A-2008228637

PCT Pub. Number WO2008/113358

Priority PA 200700423 20.03.07 DK; PCT/ DK2007/050076 15.06.07 DK; PA 200701790 14.12.07 DK; 61/013,918 14.12.07 US

Filing date 14 March 2008

Wipo publication date 25 September 2008

International Classifications

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/113358 Priority application(s): WO2008/113358

5 November 2009 Amendment Made

  The nature of the amendment is: Amend the priority details to remove US 61/013,918 14.12.2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008228638-1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition

2008228636-Perforation tool with switch